Skip to main content
OpenTrials

Clinical trial condition

Atypical Hemolytic Uremic Syndrome

Explore clinical trials studying Atypical Hemolytic Uremic Syndrome. Study availability and eligibility vary by location and protocol.

33 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Atypical Hemolytic Uremic Syndrome trial results

Recruiting

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

NCT05795140

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +18 more
Locations
  • Novartis Investigative Site São Paulo, Brazil
  • Novartis Investigative Site Rio de Janeiro, Brazil
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Ostrava, Poruba, Czechia
View Trial Details
Recruiting

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT05935215

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Novartis Investigative Site Nanjing, Jiangsu, China
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Shanghai, China
View all 31 locations
View Trial Details
Recruiting

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

NCT06312644

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +44 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Melbourne, Victoria, Australia
  • Research Site Paris, France
  • Research Site Essen, Norte-Westfalia, Germany
View Trial Details
Recruiting

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

NCT01522183

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
Locations
  • Clinical Trial Site Aurora, Colorado, United States
  • Clinical Trial Site Washington D.C., District of Columbia, United States
  • Clinical Trial Site Gainesville, Florida, United States
  • Clinical Trial Site Atlanta, Georgia, United States
View all 141 locations
View Trial Details

Related conditions